Clinical trial

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

NCT02675647

Study summary

ClinicalTrials.gov

Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Heparin, IV route, based on patients body weights (UI/kg) Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Cardiopulmonary bypass Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Protamin administration Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-12-01

PhasePHASE4

Conditions

Cardiac Surgeryunresolved

Cardiopulmonary Bypassunresolved

Obese Patients (BMI ≥ 30 kg/m²)unresolved

Interventions

Heparin, IV route, based on patients body weights (UI/kg)DRUG

Cardiopulmonary bypassPROCEDURE

Protamin administrationDRUG

Sponsors & collaborators

University Hospital, Strasbourg, Francelead sponsor

Mapped research locations

StrasbourgFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02675647 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.